BRCA Testing: What You Need to Know

What is the BRCA gene? BRCA1 and BRCA2 play a big role in preventing cancer. They belong to a class of genes called tumor suppressors, which ensure that breast, ovarian, and other types of cells don’t grow or divide too rapidly or uncontrollably. BRCA testing checks for mutations in either gene, and can help people decide … Read more

Shocked By His Breast Cancer Diagnosis, One Man Spreads the Word

Michael Tichnor still wonders what might have happened if his primary care physician did not ask him one last question during his annual physical two years ago: “Is there anything else you want to tell me?” Until that moment, Tichnor, then 66, had no plans to mention the pebble-sized bump he accidentally discovered on his … Read more

New ‘Druggable’ Genetic Targets Identified in Rare Type of Bile Duct Cancer

Scientists are beginning to make inroads into treating cholangiocarcinoma, a rare, lethal cancer of the bile ducts, with precision drugs. Last year, the first targeted drug for some patients with the disease was approved. Now, Dana-Farber scientists say they have identified another genetic alteration in a small percentage of cholangiocarcinoma patients that can be attacked … Read more

Newborn Genetic Screening for Pediatric Cancer Risk Could Save Lives

Numerous genetic mutations increase children’s risk for various cancers. When they are detected early, cancers can potentially be caught at an early, more treatable stage — or avoided entirely. Could adding such “cancer predisposition” genes to routine newborn “heel-stick” screening save lives? Lisa Diller, MD, chief medical officer at the Dana-Farber/Boston Children’s Cancer and Blood … Read more

Dramatic Turns, Epiphanies Mark Patient’s Journey with Colorectal Cancer

Khiem Tran’s response to drug therapy for advanced colorectal cancer seemed to defy the severity of his disease. After just a few doses of chemotherapy and a targeted drug, the cancer, which had spread from his rectum to his liver, was in full retreat, with a key marker of tumor burden dropping from stratospheric levels … Read more

Looking for Cancer’s Achilles Heel: The Pediatric Cancer Dependency Map

Thanks to developments in precision medicine, some adult cancers are now treated with designer drugs that target the genetic mutations that caused them. But most children with cancer have not reaped the same benefits. Unlike adult cancers, childhood cancers carry few genetic mutations. And the mutations these tumors do have are typically harder to make … Read more

Study Identifies Genes That Help Drive Growth in Melanoma Subtypes

Favoritism or impartiality? Do the four genomic subtypes of melanoma have a bias toward certain mutated genes and gene pathways, or do they welcome all mutations equally? Answering that question has been especially difficult because of cutaneous melanoma’s high mutation rate — the profusion of misspelled, severed, out-of-place, missing-in-action, or overabundant genes found in melanoma … Read more

What are Cancer Disparities and How Are Dana-Farber Researchers Addressing Them?

Despite enormous advances in cancer treatment, some racial, ethnic, and socioeconomic groups still bear an especially large burden from the disease, with higher incidence rates for many cancers and poorer outcomes. Decades of research has documented these disparities. Among adult patients, for example, African Americans have the highest mortality rate of any racial or ethnic … Read more

Ovarian Cancer Clinical Trial Helps Grandmother Feel Stable During a Difficult Year

Carol Brown, 80, has been through quite a turbulent 2020. Her much-beloved pastimes, including playing violin in a senior orchestra, book groups, and weekly church services, are now virtual due to the COVID-19 pandemic. The Boston-area resident had to cancel a March trip to visit family out west, and she spent the summer packing up … Read more

What is a Lumpectomy?

There are many different treatment options available for breast cancer, including a type of surgery called a lumpectomy. While surgery can be anxiety-inducing, rest assured that lumpectomies are extremely safe and usually take no more than an hour. Here, Anna Weiss, MD, a breast surgeon in the Breast Oncology Program at the Susan F. Smith Center for Women’s Cancers at Dana-Farber/Brigham … Read more

What’s the Difference Between BRCA1 and BRCA2?

BRCA1 and BRCA2 are cancer-susceptibility genes, meaning that people who inherit pathogenic* mutations in either one have an increased risk of developing certain cancers. Hereditary (or “germline”) mutations in BRCA1 or BRCA2 cause Hereditary Breast and Ovarian Cancer Syndrome. Having a pathogenic mutation in BRCA1 or BRCA2 doesn’t mean you will definitely develop cancer, but … Read more

Cancer Patient Faces Multiple Diagnoses with the Strength of a Warrior

One bout of cancer is enough to contend with, but since 2014 Mary Johnson has had to cope with four different cancers and related conditions. Despite these tests of her physical and emotional strength, Johnson is doing well today after treatment at Dana-Farber. “Coming to Dana-Farber gave me confidence because they supported me, and I … Read more

People with Lynch Syndrome Should Take Aspirin to Reduce Colorectal Cancer Risk, Study Suggests

Patients with Lynch syndrome, who have an elevated risk of colorectal cancer, can reduce their risk by taking daily aspirin — and the protective effect persists for many years, according to the latest definitive study. This evidence comes as a result of a clinical trial in which all subjects were followed for at least 10 … Read more